Amino acid substitutions in the sixth transmembrane domain of P-glycoprotein alter multidrug resistance.

AUTOR(ES)

Devine, S E

RESUMO

Eukaryotic cells can display resistance to a wide range of natural-product chemotheraputic agents by the expression of P-glycoprotein (pgp), a putative plasma membrane transporter that is thought to mediate the efflux of these agents from cells. We have identified, in cells selected for multidrug resistance with actinomycin D, a mutant form of pgp that contains two amino acid substitutions within the putative sixth transmembrane domain. In transfection experiments, this altered pgp confers a cross-resistance phenotype that is altered significantly from that conferred by the normal protein, displaying maximal resistance to actinomycin D. These results strongly implicate the sixth transmembrane domain in the mechanism of pgp drug recognition and efflux. Moreover, they indicate a close functional homology between pgp and the cystic fibrosis transmembrane regulator in which the sixth transmembrane domain has also been shown to influence substrate specificity.

Documentos Relacionados

• Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein
• The multidrug resistance P-glycoprotein modulates cell regulatory volume decrease.
• Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.
• Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.